Toggle Main Menu Toggle Search

Open Access padlockePrints

A Survey Exploring People's Experiences With Lithium Bought as a Supplement: Une enquête sur l’expérience des personnes avec le lithium en supplément

Lookup NU author(s): Dr David CousinsORCiD

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

© The Author(s) 2025.Objective: Lithium, despite its evidence base and range of indications, is often underutilized due to safety concerns associated with high-dose prescriptions and consequent necessity for regular blood monitoring. Emerging evidence suggests its potential benefits at lower doses, especially for its pro-cognitive effects and positive safety profile. While accessible as a supplement, empirical human evidence on neuropsychiatric effects is lacking. This study aimed to provide preliminary evidence regarding the utilization and perceived effects of low-dose lithium supplements (LiS) in the community. Methods: Cross-sectional, opportunistic survey of 211 participants aged ≥18 years who disclosed taking over-the-counter lithium supplements. The survey assessed sample demographics, supplement details, overall perspectives, and personal experiences related to the use of LiS. Results: The most common form of LiS taken was aspartate at 10 mg once per day, although lithium orotate and ionic lithium were also frequently used. The most common beliefs regarding the benefits of using lithium as a supplement concern efficacy for anxiety, but the most common improvements experienced was in the domain of cognition, closely followed by anxiety and mood. Mood was most commonly reported as the greatest improvement. Side effects and withdrawal phenomena were more prevalent than anticipated. Conclusion: This study revealed a diverse range of lithium supplements taken, in terms of dosage, formulation, frequency, and duration of intake. Anecdotal evidence highlighted prevalent perceived benefits and adverse effects. The study is, however, limited notably by its cross-sectional opportunistic design; more robust evidence, especially from controlled trials, is needed to fully establish the specific benefits and drawbacks associated with different forms and doses of accessible lithium supplements. Plain Language Summary Title: A survey exploring people's experiences with lithium bought as a supplement. Plain Language Summary Lithium is the oldest effective medication used in psychiatry and holds an important place today. However, there are challenges with lithium in high doses and it may still be effective in low doses. Lower doses of lithium can be bought as a supplement over the counter, but this version of lithium has not been studied in research. We did a survey aiming to tell us some information about the experiences of people who have taken this supplementary lithium (“LiS”). From 211 adults who completed our study, results suggested that LiS is taken in many different forms, at different doses, frequencies and for different durations. People commonly believed and/or found that LiS was beneficial for anxiety, mood and cognition. Side effects and symptoms after stopping LiS were, however, more common than expected. Because this was just an initial survey, more in depth and rigorous research studies are needed to fully understand the exact benefits and drawbacks associated with different forms and doses of accessible lithium supplements.


Publication metadata

Author(s): Strawbridge R, Myrtle S, Carmellini P, Hampsey E, Cousins DA, Young AH

Publication type: Article

Publication status: Published

Journal: Canadian Journal of Psychiatry

Year: 2025

Pages: epub ahead of print

Online publication date: 28/03/2025

Acceptance date: 02/04/2018

ISSN (print): 0706-7437

ISSN (electronic): 1497-0015

Publisher: Sage Publications Inc.

URL: https://doi.org/10.1177/07067437251328282

DOI: 10.1177/07067437251328282


Altmetrics

Altmetrics provided by Altmetric


Share